Rios, M. T.1; Dominguez-Sardiña, M.1; Pousa, L.1; Perez De Lis, J.1; Otero, A.2; Fontao, M. J.3; Fernandez, J. R.3; Ayala, D. E.3; Hermida, R. C.3 Author Information
Tomato, Solanum Lycopersicum L., is the second most consumed fruit in the world. According to the Food and Agriculture Organization (FAO, 2020), more than 180 million tons of tomatoes are produced worldwide, but, depending on the season, 5–10% are discarded for fresh consumption due to their ripening stage, colour, size or shape. This represents important losses for the producers and has a negative impact on the environment. Those tomato wastes are normally destroyed, but there is a large potential for valorization in the food supply chain. Tomato waste constitutes a largely chemical value from which a variety of valuable chemicals can be derived. On the other hand, it can be used in animal feed, composting and vermiculture and as a substrate for microbial growth, being an excellent biological source.
Hermida, R C; Calvo, C; Ayala, D E; Lopez, J E; Dominguez, M J; Covelo, M; Fontao, M J; Soler, R; Mojon, A; Fernandez, J R Author Information
The relationship between the structural properties of selected dietary polyphenols and their affinities for bovine hemoglobin (bHB) was investigated by fluorescence analysis. The presence of an additional methoxy group on flavonoids weakened the affinities for bHB by 1.15-13.80 times. Hydroxylation on rings A, B, and C also significantly affected the affinity for bHB. The glycosylation of flavonoids decreased the affinities for bHB by 1 order of magnitude depending on the conjugation site and the class of sugar moiety. Hydrogenation of the C2═C3 double bond also decreased the binding affinity. The galloylated catechins exhibited higher binding affinities for bHB than nongalloylated. The glycosylation of resveratrol increased its affinity for bHB. The binding process with bHB was strongly influenced by the structural differences of dietary polyphenols. The affinities for bHB increased with increasing partition coefficients and decreased with increasing hydrogen bond donor and acceptor numbers of polyphenols, which suggested that the binding interaction was mainly caused by the hydrophobic force.
BACKGROUND AND PURPOSE Neuroprotection is an important strategy for ischemic stroke treatment. Cajaninstilbene acid (CSA), a unique stilbenoid with a styryl group, is a potential neuroprotective agent. Hence, this study aimed to evaluate the neuroprotective effect and molecular mechanism of CSA against cerebral ischemia/reperfusion (I/R) damages. EXPERIMENTAL APPROACH The ischemic stroke was modeled by oxygen and glucose deprivation/reoxygenation (OGD/R) in SH-SY5Y cells and transient middle cerebral artery occlusion/reperfusion (MCAO/R) in rats. Tert-butyl hydroperoxide (t-BHP) was used to induce oxidative stress in cells. The signaling pathways were analyzed by Western blotting and inhibitor blocking. KEY RESULTS CSA possessed significant neuroprotective activity, as evidenced by the reduced cell death in OGD/R or t-BHP injured cells, and decreased infarct volume and neurological deficits in MCAO/R rats. Further studies indicated that the protective effect was achieved via the antioxidant activity of CSA, which decreased the oxidative stress and its related mitochondrial dysfunction in cells. Notably, Nrf2 was activated in cells and MCAO/R rats by CSA, and the inhibition of Nrf2 by brusatol weakened CSA-mediated neuroprotection. Furthermore, after applying a series of kinase inhibitors, CSA-induced Nrf2 activation was markedly inhibited by BML-275 (an AMPK inhibitor), implying that AMPK was the dominant kinase to regulate the Nrf2 pathway for CSA’s neuroprotective effects with enhanced AMPK phosphorylation observed both in vivo and in vitro. CONCLUSION AND IMPLICATION CSA exerted neuroprotection via activating AMPK/Nrf2 pathway to reduce I/R-induced cellular oxidative stress and mitochondrial disfunction. CSA could be a potential neuroprotective drug candidate for the treatment of ischemic stroke.
The lack of nocturnal decline in lood pressure (BP) has been associated with an increase in end-organ-damage and cardiovascular events [Verdecchia et al. Hypertension 1994;24:793-801], although results are still controversial partly due to the inability to properly reproduce over time the classification of patients into dippers and non-dippers [Omboni et al. J Hypertens 1988;16:733-738]. Moreover, the non-dipping status has been frequently related to an increase in nocturnal activity and/or differences in quality of sleep [Kario et al. Hypertension 1999;34:685-691]. With the aim to assess the relationship between activity and BP, we studied 160 mild-to-moderate hypertensive patients (82 men), 54.2±1.3 (mean±SE) years of age. BP was measured at 20-minute intervals during the day and at 30-minute intervals at night for 48 consecutive hours with an ambulatory Spacelabs 90207 device. Physical activity was simultaneously monitored by wrist actigraphy. Circadian parameters of BP and activity established by population multiple-components analysis [Fernández & Hermida. Chronobiol Int 1998;15:191-204] were compared between dippers (n=67) and non-dippers (systolic nocturnal decline<10%) by nonparametric testing. Diurnal and nocturnal means of BP and activity were computed for each patient according to individual resting hours determined by actigraphy. Despite highly statistically significant differences in nocturnal mean as well as in each hourly nightly mean of BP between dippers and non-dippers, there were no differences on those parameters in activity. Duration of sleep as well as 24-hour mean and standard deviation of activity were also similar between groups (P>0.108), although non-dippers have a slightly decrease in diurnal mean of activity (P=0.030). The highly significantly different circadian variation in BP between dipper and non-dipper patients with essential hypertensive is not related to a significant increase in nocturnal physical activity.